Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
Clinical trial NCT03610516 · COMPLETED
Trial details
- NCT number
- NCT03610516
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-12
- Primary completion
- 2023-06-29
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.